Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Oncology

Expert Opinion / Interview · November 18, 2014

Transformative Moments in Oncology: Curative Combination Therapy for Cancer

Vincent DeVita
Interview by
Bojia Li MD
Gregg Sutton MD
Lee S. Schwartzberg MD, FACP
Interview with
Vincent DeVita MD

 

 Save  Recommend
 Share

Additional Info

  1. DeVita VT, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med. 1970;73(6):881-895.

  2. Moore MR, Jones SE, Bull JM, et al. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients. Cancer. 1973;32(1):52-60.

  3. DeVita VT, Canellos GP, Chabner B, et al. Advanced diffuse histiocytic lymphoma, a potentially curable disease. Results with combination chemotherapy. Lancet. 1975;1(7901):248-250.

  4. Longo DL, Young RC, Wesley M, et al. Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol. 1986;4(9):1295-1306.

  5. Bonadonna G, Zucali R, Monfardini S, et al. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer. 1975;36(1):252-259.

  6. Canellos GP, Anderson JR, Propert KJ, et al. Chemotherapy of advanced Hodgkin’s disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med. 1992;327(21):1478-1484.
  7. Tran E, Turcotte S, Gros A, et al. Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer. Science. 2014;344(6184):641-645.

  8. Hanahan D, Weinberg RA. Hallmarks of Cancer. An organizing principle for cancer medicine. In DeVita VT, Jr, Lawrence TS, Rosenberg SA (eds). DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology, 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2014; chap 2:24-44.

Disclosure statements are available on the authors' profiles:

Lee Schwartzberg MD, FACP

Further Reading

Most Read This Week

Recently Updated